Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 12, 2022
Patent Application Number
16664168
Date Filed
October 25, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
The present invention relates to amylin analogues and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogues have good physical and chemical stability, good solubility, and a long duration of action, and are well suited for use in the form of a liquid formulation.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
